In an effort to improve health care quality by fostering collaboration, a consortium of Medication Safety Officers from ASMSO have agreed to work together to enhance the knowledge of, and leading to a reduction in medication administration errors and readmission rates in acute care hospitals.
Why have those particular patient populations been singled out as worthy of attention? The literature suggests that, in each case, they continue to be high risk; errors are more frequent and the potential for catastrophic consequence is higher in these patient populations relative to the general adult population.
Taken together, these observations from the literature and recent guideline updates suggest that gaps in practice exist in these patient populations – gaps that the proposed learning activities will attempt to bridge.
In this online free CME / CE program , the presentations will be conducted using a case study format identifying areas of safety that have been successful based upon each of the practice areas noted. These presentations will achieve objectives including; Identify factors of the patient population that increase the risk for medication errors, discuss risk reduction strategies for the particular patient population that can be applied to the medication-use process, completing, development of a list of root causes of medication administration errors, determining the economic cost to the system of these errors, development of data collection protocols, and an effort in the participating hospitals to utilize this information to reduce medication administration errors at their facilities.
Agenda:
Introduction, Disclosures
The population at a glance
• Who are the elderly?
• Elderly medication use statistics
Key concepts
• Preventable causes of drug-related problems
• Drug-specific risk factors
• Polypharmacy
• Altered pharmacokinetics and pharmacodynamics
Medication errors in elderly hospitalized patients
• Incidence and definitions
• The role of medication reconciliation
• Risk reduction strategies
Case studies
Putting it all together: best practices, summary, and conclusions
Healthcare professionals including: geriatricians, mid-level practitioners working in acute care hospitals and other healthcare settings, medication safety officers, staff and clinical pharmacists, and pharmacists who otherwise have an interest in geriatric care or whose practice involves geriatric patients.
Commercial Support Disclosure: This program is supported by educational grants from Boehringer Ingelheim and Hospira.
Release Date: September 26, 2013 -- Expiration Date: September 26, 2015
Faculty: Marilyn Bulloch, PharmD
By the end of the session the participant will be able to:
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of ScientiaCME and The American Society of Medication Safety Officiers (ASMSO). ScientiaCME is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation: ScientiaCME designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™ toward the AMA Physician's Recognition Award. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Pharmacists
Educational Review Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmaceutical education. This program is approved for 0.5 hours (0.05CEUs) of continuing. Proof of participation will be posted to your NABP CPE profile within 4 to 6 weeks to participants who have successfully completed the post-test. Participants must participate in the entire presentation and complete the course evaluation to receive continuing pharmacy education credit. ACPE # 0761-9999-13-104-H01-P
This course is not valid for CE credit after 9/25/2015
This program is free of cost. Successful completion of the post-test and completion of the program evaluation is required to obtain a CME certificate.
Note: ACCREDITATION HAS EXPIRED FOR THIS PROGRAM.
As an provider of continuing medical education, it is the policy of ScientiaCME to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, faculty and educational planners must disclose any significant relationships with commercial interests whose products or devices may be mentioned in faculty presentations, and any relationships with the commercial supporter of the activity. The intent of this disclosure is to provide the intended audience with information on which they can make their own judgments. Additionally, in the event a conflict of interest (COI) does exist, it is our policy to ensure that the COI is resolved in order to ensure the integrity of the CME activity. For this CME activity, any COI has been resolved thru content review by ScientiaCME.
Faculty Disclosure: Marilyn Bulloch, PharmD, reports that she has no relevant financial disclosures.
Disclosures of Educational Planner: Charles Turck, PharmD has no relevant financial disclosures.
Disclosures of Educational Planner: Ambra King, PharmD (ASMSO) has no financial disclosures.
Commercial Support Disclosure: This program is supported by educational grants from Boehringer Ingelheim and Hospira.
*Required to view Printable PDF Version
Please take a few minutes to participate in the optional pre-test. It will help us measure the knowledge gained by participating in this activity.